Foghorn Therapeutics takes aim at chromatin hijackers to stop cancer
Tuesday, May 28, 2019 - 22:26
in Health & Medicine
The start-up, cofounded by Cigall Kadoch, is drugging a molecular machine called BAF, part of the chromatin regulatory system